- Home
- AAPG vs GNW Comparison
AAPG vs GNW Comparison
Compare AAPG & GNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAPG | GNW |
|---|---|---|
| Founded | 2009 | 1871 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.4B |
| IPO Year | 2025 | 2004 |
Fundamental Metrics
Financial Performance| Metric | AAPG | GNW |
|---|---|---|
| Price | $32.88 | $8.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $48.50 | $10.00 |
| AVG Volume (30 Days) | 5.1K | ★ 4.1M |
| Earning Date | 11-19-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 160.86 |
| EPS | N/A | ★ 0.52 |
| Revenue | $54,524,554.00 | ★ $7,299,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $368.64 | N/A |
| P/E Ratio | ★ N/A | $14.90 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.50 | $5.99 |
| 52 Week High | $48.45 | $9.15 |
Technical Indicators
Market Signals| Indicator | AAPG | GNW |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 53.98 |
| Support Level | $30.00 | $8.54 |
| Resistance Level | $33.09 | $8.75 |
| Average True Range (ATR) | 0.83 | 0.19 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 72.07 | 74.60 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About GNW Genworth Financial Inc
Genworth Financial Inc is a diversified insurance holding company that provides various mortgage and life insurance products. The company has three main operating business segments: Enact, Life and Annuities segment and Long-Term Care Insurance. The company's product portfolio includes various financial products such as traditional life insurance, mortgage insurance, fixed annuities, and variable annuities. Majority of the revenue is generated by the Enact segment. The company earns maximum of its revenue in the United States.